Colorectal Cancer Targeted with Mass-Produced iPSC-Derived Allogeneic T Cells
Researchers at Kobe University have generated off-the-shelf, mass-producible induced pluripotent stem cell (iPSC)-derived gamma delta T cells (γδT cells) that in a small preclinical study suppressed tumor growth in mouse colorectal cancer (CRC) xenograft models. The team says their development could point to the potential for developing faster, cheaper cancer immunotherapy.
China’s Summer Grain Output Exceeds 150 Million Tonnes
July 2026, Beijing: China’s summer grain output reached a record 150.75 million tonnes this year, surpassing the 1…
USSEC Highlights How High-Quality Sustainable Feed Ingredients Can Boost the Region’s Aquaculture Performance
Investing in superior quality aquafeed is essential for aquaculture’s long-term success. At AquaCON, hosted by the U.S. Soybean Export Council (USSEC) in collaboration with WorldFish Egypt, U.S. soybean farmers, educators, nutritionists, and aquaculture’s most prominent voices from across the Middle East, North Africa and South Asia (MENASA) region gathered to discuss forward-thinking strategies, best practices, and the role of feed in sustainably growing the industry.
Corteva and Arevo Partner on Soy Crop Nutrition
Corteva, a global pure-play agriculture company, and Arevo, a Swedish science-led crop nutrition company, have announced a partnership on Arginex Soy, Arevo’s seed applied crop nutrition system.
AgriFood Signals: Trump tariffs on Canada, McCormick + Unilever merger, Coca-Cola’s Fairlife hacked
AgFunderNews rounds up the most important fundings, mergers, acquisitions, closures, and industry buzz in agtech and foo…
Agragene”借道”Pairwise Fulcrum®平台，pgSIT不育昆虫技术再获CRISPR”引擎”
世界农化网中文网报道：2026年7月23日，总部位于北卡罗来纳州达勒姆的农业基因编辑领军企业Pairwise，与总部位于密苏里州圣路易斯的可持续农业技术公司Agragene达成Fulcrum® CRISPR平台授权协议。这是Fulcrum®平台首次被应用于昆虫体系，标志着CRISPR技术从植物育种向害虫生物防治的跨域延伸。
Munich’s biotech hub: Inside one of Europe’s leading life sciences ecosystems
Munich has long been recognized as one of Germany’s scientific powerhouses, but in recent years it has also emerged as one of Europe’s most dynamic biotech and life sciences ecosystems. Bringing together leading academic institutions, multinational pharmaceutical companies, cutting-edge startups, and strong investment, the region has created an environment that consistently translates scientific research into commercial innovation.
CHMP backs Minoryx’s rare disease drug two years after rejection
Why it matters: The comeback gives Minoryx a potential route to the first pharmacological treatment for cerebral adrenoleukodystrophy (cALD), but only in a narrowly defined group of young patients.
Moa Technology raises $30m to advance novel modes of action in weed management
UK-based Moa Technology has raised a £22.2 million ($29.6 million) Series C round to further advance its discovery platf…
China’s Rural Investment, Consumption Register Steady Growth In H1
July 2026, Beijing: China’s investment and consumption in rural areas achieved solid growth in the first half (H1)…